POU5F1 and sarcoma: In addition, after verifying the expression of IFNβ receptors (IFNAR1/2) in sarcoma cells (Supplementary Figure S5A-B), we directly treated sarcoma cells with IFNβ, showing a dose-dependent OCT4 upregulation at both the mRNA and protein levels (Fig. 4C–D).